Drug Discovery.
Humanized.
The Next-Generation Organ-on-a-Chip Platform
We deliver clinically-relevant mechanistic data to develop efficacious and safe therapies faster.
A mechanistic understanding of the interplay between drugs and human physiology is the foundation of developing safe and efficacious therapies. While advanced therapeutic modalities now offer unprecedented precision in targeting diseases, traditional preclinical models are lagging behind. They fail to reflect the human specificity and disease heterogeneity needed to accurately predict clinical responses, fueling the persistent threat of late-stage clinical attrition.
Javelin Biotech is redefining the preclinical standard. Our physiologically-relevant human microphysiological systems (MPS) capture both the biological complexity and human specificity missing from traditional models. By enabling pharmacologically relevant studies across a range of drug modalities, the Javelin platform generates the longitudinal, and high-content data required to accurately predict human response. Delivering clinically-relevant insights earlier in the discovery process empowers you to identify the most promising candidates faster and with greater precision than traditional methods - accelerating the path to life-saving therapies.